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In modern society, there is increasing demand for 
healthcare interventions to be economically viable 
and cost-effective. To quantify this, the number of 
quality-adjusted life-years (QALYs) delivered by 
the intervention is calculated, based on the Euro-
Qol five-dimension (EQ-5D) score and population 
demographics such as life expectancy. The EQ-5D 
score measures five domains, scoring each at three 
levels of severity (mild, moderate, severe), giving 
243 possible health profiles. These profiles can 
then be converted into a single absolute utility 
score. For the United Kingdom population, these 
scores range from -0.594 to 1, with a score of 1 
representing full health and 0 death.1 Negative 
scores define, therefore, a state ‘worse than death’ 
(WTD). Of the 243 possible health states, 84 have 
negative utility scores and hence are deemed 
WTD. The ability to score health states WTD 
enables a broader description of severe disability 
and severely poor health, thereby lessening the 
floor effect of this score. The measure is reliable, 
responsive, and validated in a number of popula-
tions and conditions including arthropathy.2-4
Total hip arthroplasty (THA) and total knee 
arthroplasty (TKA) for end-stage degenerative 
joint disease (DJD) are both extremely clinically 
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Aims
The EuroQol five-dimension (EQ-5D) questionnaire is a widely used multiattribute general 
health questionnaire where an EQ-5D < 0 defines a state ‘worse than death’ (WTD). 
The aim of this study was to determine the proportion of patients awaiting total hip 
arthroplasty (THA) or total knee arthroplasty (TKA) in a health state WTD and to identify 
associations with this state. Secondary aims were to examine the effect of WTD status on 
one-year outcomes.
Patients and Methods
A cross-sectional analysis of 2073 patients undergoing 2073 THAs (mean age 67.4 years 
(sd 11.6; 14 to 95); mean body mass index (BMI) 28.5 kg/m2 (sd 5.7; 15 to 72); 1253 female 
(60%)) and 2168 patients undergoing 2168 TKAs (mean age 69.3 years (sd 9.6; 22 to 91); BMI 
30.8 kg/m2 (sd 5.8; 13 to 57); 1244 female (57%)) were recorded. Univariate analysis was 
used to identify variables associated with an EQ-5D score < 0: age, BMI, sex, deprivation 
quintile, comorbidities, and joint-specific function measured using the Oxford Hip Score 
(OHS) or Oxford Knee Score (OKS). Multivariate logistic regression was performed. EQ-5D 
and OHS/OKS were repeated one year following surgery in 1555 THAs and 1700 TKAs.
Results
Preoperatively, 391 THA patients (19%) and 263 TKA patients (12%) were WTD. Multivariate 
analysis identified preoperative OHS, deprivation, and chronic obstructive pulmonary 
disease in THA, and OKS, peripheral arterial disease, and inflammatory arthropathy in TKA 
as independently associated with WTD status (p < 0.05). One year following arthroplasty 
EQ-5D scores improved significantly (p < 0.001) and WTD rates reduced to 35 (2%) 
following THA and 53 (3%) following TKA. Patients who were WTD preoperatively achieved 
significantly (p < 0.001) worse joint-specific Oxford scores and satisfaction rates one year 
following joint arthroplasty, compared with those not WTD preoperatively.
Conclusion
In total, 19% of patients awaiting THA and 12% awaiting TKA for degenerative joint disease 
are in a health state WTD. Although specific comorbidities contribute to this, hip- or knee-
specific function, mainly pain, appear key determinants and can be reliably reversed with 
an arthroplasty.
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Fig. 1
Frequency density graph of preoperative EuroQol five-dimension  
(EQ-5D) index in patients awaiting total hip arthroplasty (THA) and at 
one year following THA.
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and cost-effective: cost per QALY is £1372 and £2101 for 
THA and TKA, respectively.5 Both procedures are considera-
bly cheaper than the £20 000 per QALY for a procedure to be 
defined as cost-effective. Despite this, in a financially pressured 
healthcare system there is pressure to reduce, and possibly even 
ration, their use. The assumption appears to be that leaving 
patients with DJD in pain to deteriorate is benign when com-
pared with other healthcare needs.
The aim of this study was to identify the number of patients 
with end-stage DJD awaiting hip or knee arthroplasty surgery 
whose health state was defined as WTD by the EQ-5D score, 
and to identify associations with this state. Secondary aims 
included examining the influence of waiting times on WTD 
status and of WTD status on the outcome of joint arthroplasty 
surgery at one year.
Patients and Methods
Ethical approval was obtained for this cross-sectional study 
(Scotland (A) Research Ethics Committee 16/SS/0026). 
Between January 2014 and September 2017 data were recorded 
for 2206 consecutive patients undergoing primary THAs and 
2394 primary TKAs. Data pertaining to the second arthroplasty 
in patients who underwent bilateral procedures during the 
study period were excluded, leaving study populations of 2073 
patients undergoing THA and 2168 TKA.
Standard prostheses were cemented THAs utilizing an Exeter 
stem and a Contemporary acetabular component (Stryker Ortho-
paedics, Mahwah, New Jersey) and cemented, cruciate-retaining 
Triathlon TKAs (Stryker Orthopaedics), with surgery performed 
or supervised by 12 surgeons at a large orthopaedic teaching 
hospital. Patients followed standardized postoperative rehabili-
tation following THA and similarly following TKA. All patients 
followed a uniform departmental rehabilitation care plan.
Preoperatively, patients completed questionnaires including 
a detailed comorbidity questionnaire, general health (EQ-5D), 
and joint-specific (Oxford Hip Score (OHS) or Oxford Knee 
Score (OKS)) patient-reported outcome measures (PROMs). 
Specifically, the questionnaire asked about the presence of the 
following conditions: myocardial infarction, congestive heart 
failure, peripheral arterial disease (PAD), stroke with hemiple-
gia, dementia, chronic obstructive pulmonary disease (COPD), 
connective tissue disorder, diabetes, kidney disease and liver 
disease, back pain, and pain in other joints. Preoperative ques-
tionnaires were collected at a preassessment clinic two weeks 
prior to surgery, when additional demographical data including 
age, sex, body mass index (BMI), and postcode were recorded 
by the research team. At one year postoperatively, question-
naires included EQ-5D, OHS/OKS, and a measure of patient 
satisfaction using a five-point Likert scale with the options 
‘very satisfied’, ‘satisfied’, ‘uncertain’, ‘dissatisfied’, and ‘very 
dissatisfied’. These were completed independently of routine 
care and were administered via post.
The EQ-5D score provides a validated and standardized 
measure of five health domains (mobility, self-care, ability to 
perform usual activities, pain/discomfort, and anxiety/depres-
sion), each rated 1 to 3 (no problems; moderate difficulties; 
severe difficulties) in addition to two visual analogue scales 
of health and pain (scale 0 to 100).6 The OHS and OKS are 
validated hip- and knee-specific outcome measures, respec-
tively, where 12 questions (five possible answers) give scores 
from 0 to 48 (higher scores = better function).7,8 The patient’s 
postcode was used to assign Scottish Index of Multiple Depri-
vation (SIMD) quintiles.9 The SIMD ranks geographical areas 
based upon seven domains: income, employment, education, 
housing, health, crime, and geographical access. Data zones are 
defined by postcodes and once ranked nationally are divided 
into population-weighted quintiles with 1 representing the most 
deprived and 5 representing the least deprived.
Waiting list data were acquired from our local waiting list 
office. For patients who were placed on the waiting list at their 
first orthopaedic outpatient (OP) review, the time from primary 
care referral to orthopaedic review and the time from review 
to surgery were individually calculated. Patients who had been 
reviewed multiple times in OP clinics prior to listing were not 
included in the waiting time evaluation, as the basis of the delay 
to surgery was uncertain.
Statistical analysis. Data were analyzed using SPSS version 
21.0 (IBM, Armonk, New York). Univariate analysis was per-
formed using parametric (Student’s t-test: paired and unpaired) 
and nonparametric (Mann–Whitney U test, Wilcoxon’s signed-
rank test) tests, as appropriate, to assess differences in continu-
ous variables between groups (WTD and not WTD; responders 
and nonresponders; persistent and resolved WTD status). Nom-
inal categorical variables were analyzed using chi-squared test 
or Fisher’s exact test. Pearson’s correlation coefficient was used 
to assess the relationship between linear variables.  Variables 
found to be associated with a health state WTD at the 10% level 
or less were entered stepwise into a multivariate binary logis-
tic regression analysis, using an enter methodology, to identify 
independent associations with WTD status. The same method 
was employed to identify associations with persistent postop-
erative WTD status. A p-value < 0.05 was considered statisti-
cally significant. Receiver operating characteristic (ROC) curve 
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Table I. Univariate analysis of associations with ‘worse than death’ (WTD) status (EuroQol five-dimension (EQ-5D) < 0) prior to total hip arthroplasty 
(THA) and total knee arthroplasty (TKA)
Variable Hips Knees
WTD  
(n = 391)
Not WTD  
(n = 1682)
p-value WTD  
(n = 260)
Not WTD  
(n = 1907)
p-value
Mean age, yrs (sd) 67.3 (12.8) 67.4 (11.3) 0.919* 68.9 (10.3) 69.4 (9.4) 0.478*
Mean body mass index, kg/m2 (sd) 29.9 (6.3) 28.2 (5.5) < 0.001*† 32.3 (6.4) 30.6 (5.7) < 0.001*†
Sex, female, n (%) 280 (72) 973 (58) < 0.001†‡ 183 (68) 1060 (55) < 0.001†‡
SIMD, n (%)
1 40 (10) 118 (7) < 0.001†‡ 31 (12) 158 (8) 0.006†‡
2 113 (29) 266 (16) 75 (29) 364 (19)
3 58 (15) 304 (18) 42 (16) 368 (19)
4 94 (24) 390 (23) 52 (20) 443 (23)
5 86 (22) 604 (36) 60 (23) 574 (30)
Medical comorbidity, n (%)
Myocardial infarction 15 (4) 56 (3) 0.620‡ 11 (4) 93 (5) 0.621‡
Heart failure 5 (1) 11 (1) 0.204‡ 3 (1) 17 (1) 0.692‡
Peripheral arterial disease 5 (1) 25 (1) 0.757‡ 12 (5) 31 (2) 0.001†‡
Stroke with hemiplegia 17 (4) 34 (2) 0.007†‡ 7 (3) 49 (3) 0.930‡
Dementia 11 (3) 10 (1) < 0.001†‡ 1 (0.4) 8 (0.4) 0.926‡
Chronic obstructive pulmonary disease 38 (10) 52 (3) < 0.001†‡ 15 (6) 79 (4) 0.244‡
CTD/inflammatory arthropathy 84 (21) 153 (9) < 0.001†‡ 70 (27) 296 (16) < 0.001†‡
Diabetes 37 (9) 131 (8) 0.497‡ 28 (11) 241 (13) 0.358‡
Kidney disease 10 (3) 29 (2) 0.275‡ 7 (3) 42 (2) 0.638‡
Liver disease 14 (4) 18 (1) < 0.001†‡ 4 (2) 24 (1) 0.724‡
Median number of medical comorbidities (IQR) 0 (0 to 5) 0 (0 to 9) < 0.001†§ 1 (0 to 2) 0 (0 to 1) < 0.001†§
Musculoskeletal comorbidity, n (%)
Back pain 159 (41) 566 (34) < 0.001†‡ 136 (52) 731 (38) < 0.001†‡
Pain in other joints 199 (51) 822 (49) < 0.001†‡ 205 (78) 1315 (69) < 0.003†‡
Bilateral joint arthroplasties 31 (8) 82 (5) 0.017†‡ 16 (6) 133 (7) 0.481‡
Mean PROM (sd)
EQ-5D health 52.6 (24.3) 70.8 (20.14) < 0.001†§ 57.6 (22.8) 71.4 (19.7) < 0.001*†
EQ-5D pain 39.9 (25.7) 53.7 (22.1) < 0.001*† 44.5 (24.4) 52.9 (22.1) < 0.001*†
Preoperative Oxford score 11.0 (5.6) 21.7 (7.8) < 0.001*† 14.1 (7.2) 21.0 (7.6) < 0.001*†
*Unpaired Student’s t-test
†Statistically significant
‡Chi-squared test
§Mann–Whitney U test
SIMD, Scottish Index of Multiple Deprivation; CTD, connective tissue disorder; IQR, interquartile range; PROM, patient-reported outcome measure
analysis was used to identify the threshold OHS or OKS asso-
ciated with WTD status. The area under the ROC curve ranges 
from 0.5, indicating a test with no accuracy, to 1.0, indicating 
perfect accuracy. The threshold value is the point of maximal 
sensitivity and specificity in predicting WTD.
Results
Hips. Between January 2014 and September 2017, 2073 THAs 
were performed in 2073 consecutive patients: mean age, 67.4 
years (sd 11.6; 14 to 95); mean BMI, 28.5 kg/m2 (sd 5.7; 15 to 
72); 1253 patients (60.4%) were female, 1982 patients (95.6%) 
had primary osteoarthristis.
While awaiting THA, the median EQ-5D index was 0.364 
(interquartile range (IQR) 0.06 to 0.69), six patients (0.3%) had 
an EQ-5D status of full health (EQ-5D index = 1.0), and 391 
(18.9%) had negative scores WTD (Fig. 1). Of 391 patients 
with scores defined as WTD, 389 (99%) reported extreme 
levels of pain and 76 (20%) extreme levels of anxiety and 
depression. Univariate analysis identified a number of variables 
significantly (p < 0.05) associated with WTD status (Table I). 
Multivariate analysis identified the preoperative OHS and the 
presence of COPD to be independently associated with WTD 
status prior to hip arthroplasty (Table II).
The preoperative EQ-5D status correlated with the preoper-
ative OHS (R = 0.698; p < 0.01, Pearson’s correlation coeffi-
cient), the EQ-5D health score (R = 0.394; p < 0.01), and the 
EQ-5D pain score (R = 0.312; p < 0.01). Preoperative OHSs 
were significantly worse in those with WTD status (Table I, 
Fig. 2).
ROC analysis using the OHS to predict WTD status gave 
an area under the curve of 0.87 (95% confidence interval (CI) 
0.85 to 0.88; p < 0.001; Fig. 3). A threshold OHS of 14.5 gave a 
sensitivity of 82% and a specificity of 75% for identifying those 
WTD. Significant differences were found in the responses to 
every individual question of the OHS preoperatively between 
those WTD and those not (p < 0.001, chi-squared test).
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One year following THA, 16 patients had died and 
1555/2046 surviving patients (76%) completed PROMs. Sur-
viving responders and nonresponders are compared in Table III. 
In responders, the median EQ-5D index improved significantly 
to 0.796 (p < 0.001, Wilcoxon’s signed rank test): 615/1555 
patients (40%) had an EQ-5D index of 1.0 (i.e. full health) and 
35 patients (2%) had negative scores and were WTD. Patients 
WTD preoperatively achieved a significantly greater improve-
ment in OHS following THA (Table IV), but their mean OHS 
remained significantly worse than those not WTD preopera-
tively at one year (33.3 (sd 10.4) vs 41.0 (sd 7.9); p < 0.001, 
Mann–Whitney U test; Fig. 2), a difference exceeding the mini-
mal clinically important difference for this score of 5.10 Preoper-
ative WTD status was significantly associated with satisfaction 
at one year: 206/242 WTD (85%) versus 1179/1286 not WTD 
(92%; p = 0.011, chi-squared test).
A total of 19 patients were persistently WTD at one year. Uni-
variate analysis of those persistently WTD compared with those 
no longer WTD demonstrated significant differences in specific 
comorbidities and PROMs. Multivariate analysis of associ-
ations significant at the < 10% level (Table V) identified poor 
improvement in OHS to be the only independent association with 
persistent WTD status (p < 0.001). WTD rate at one year follow-
ing THA was significantly higher in those WTD preoperatively: 
19/248 (8%) versus 16/1307 (1%) (p < 0.001, chi-squared).
Waiting list data were available for 892 THA patients (141 
WTD). Over the study period, the mean waiting time for both 
OP clinic review (p < 0.001, analysis of variance (ANOVA)) 
and surgery (p < 0.001, ANOVA) increased significantly. 
Between 2014 and 2017 mean OP waiting time increased from 
10.8 weeks (sd 3.3) to 21.0 weeks (sd 11.0; p < 0.001, Student’s 
t-test); mean surgery waiting time increased from 13.0 weeks 
(sd 5.5) to 15.7 weeks (sd 6.5; p < 0.001, Student’s t-test). 
WTD status did not vary across the years studied (p = 0.713, 
chi-squared test). Patients reporting WTD status waited a mean 
shorter time for OP review (13.8 weeks (sd 8.1) vs 15.4 weeks 
(sd 7.5); p = 0.018) and for surgery (12.3 weeks (sd 5.0) vs 13.6 
weeks (sd 5.8); p = 0.001).
Knees. Between January 2014 and September 2017, 2168 
TKAs were performed in 2168 patients: mean age, 69.3 years 
(sd 9.6; 22 to 91); mean BMI, 30.8 kg/m2 (sd 5.8; 13 to 57); 
1244 patients (57%) were female.
Table II. Multivariate logistic regression analysis of predictors of ‘worse than death’ (WTD) status 
prior to total hip arthroplasty (THA) and total knee arthroplasty (TKA)
Predictors in the model B OR (95% CI) p-value
Hips (R2 = 0.411)
Body mass index -0.01 0.99 (0.96 to 1.0) 0.521
Sex, female 0.10 1.1 (0.74 to 1.63) 0.627
Scottish Index of Multiple Deprivation 0.08 1.1 (0.95 to 1.24) 0.038
Joint-specific PROM
Preoperative Oxford Hip Score 0.20 1.21 (1.18 to 1.26) < 0.001*
Medical comorbidities
Stroke with hemiplegia 0.35 1.4 (0.50 to 4.0 0.515
Dementia 1.58 4.9 (0.81 to 29.3) 0.084
Chronic obstructive pulmonary disease 1.49 4.4 (1.9 to 10.3) 0.001*
CTD/inflammatory arthropathy 0.56 1.7 (0.96 to 3.2) 0.067
Liver disease 0.57 1.76 (0.49 to 6.4) 0.400
Total number of medical comorbidities 0.11 1.11 (0.84 to 1.48) 0.458
Musculoskeletal comorbidities
Back pain 0.40 1.5 (0.99 to 2.2) 0.054
Pain in other joints 0.30 1.4 (0.80 to 2.3) 0.265
Bilateral THAs -0.54 0.58 (0.29 to 1.16) 0.126
Knees (R2 = 0.382)
Body mass index -0.04 0.99 (0.96 to 1.03) 0.790
Sex, female 0.21 1.24 (0.82 to 1.87) 0.309
Scottish Index of Multiple Deprivation 0.05 1.05 (0.91 to 1.22) 0.505
Year of surgery -0.16 0.85 0.72 to 1.02) 0.081
Joint-specific PROM
Preoperative Oxford Knee Score 0.23 1.26 (1.22 to 1.31) < 0.001*
Medical comorbidities
Peripheral arterial disease 1.57 4.79 (1.57 to 14.58) 0.006*
CTD/inflammatory arthropathy 0.72 2.05 (1.24 to 3.40) 0.005*
Total number of medical comorbidities 0.03 1.03 (0.84 to 1.26) 0.774
Musculoskeletal comorbidities
Back pain 0.04 1.04 (0.69 to 1.55) 0.856
Pain in other joints 0.35 1.41 (0.85 to 2.35) 0.186
*Statistically significant
OR, odds ratio; CI, confidence interval; PROM, patient-reported outcome measure; CTD, connective 
tissue disorder
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Fig. 2
Chart showing Oxford Hip Scores (OHSs) prior to and one year following 
total hip arthroplasty (THA) in patients with preoperative ‘worse than 
death’ (WTD) status (EuroQol five-dimension (EQ-5D) < 0) and in those 
not WTD (EQ-5D > 0). Error bars represent 95% confidence intervals.
Fig. 3
Receiver operating characteristic (ROC) curve for ‘worse than death’ 
(WTD) status and Oxford Hip Score prior to total hip arthroplasty (THA; 
area under curve = 0.87). Diagonal segments are produced by ties.
Table III. Characteristics of responders and nonresponders to one-year patient-reported outcome measures (PROMs)
Variable Hips Knees
Nonresponder  
(n = 518)
Responder  
(n = 1555)
p-value Nonresponder  
(n = 452)
Responder  
(n = 1697)
p-value
Mean age, yrs (sd) 65.6 (11.1) 68.0 (11.7) < 0.001*† 68.1 (10.2) 69.7 (9.3) 0.002*†
Mean body mass index, kg/m2 (sd) 29.5 (6.3) 28.2 (5.5) < 0.001*† 31.7 (6.4) 30.6 (5.6) < 0.001*†
Sex, female, n (%) 318 (61) 935 (60) 0.618‡ 174 (38) 753 (44) 0.004†‡
Medical comorbidity, n (%)
Myocardial infarction 22 (4) 49 (3) 0.235‡ 31 (7) 73 (4) 0.040†‡
Heart failure 5 (1) 11 (1) 0.561‡ 3 (1) 17 (1) 0.466‡
Peripheral arterial disease 5 (1) 25 (2) 0.298‡ 9 (2) 34 (2) 0.902‡
Stroke with hemiplegia 12 (2) 39 (3) 0.808‡ 20 (4) 36 (2) 0.01†‡
Dementia 4 (1) 17 (1) 0.527‡ 3 (1) 6 (1) 0.396‡
Chronic obstructive pulmonary disease 32 (6) 58 (4) 0.018†‡ 28 (6) 66 (4) 0.052‡
CTD/inflammatory arthropathy 76 (15) 161 (10) 0.007†‡ 97 (21) 269 (16) 0.014†‡
Diabetes 49 (9) 119 (8) 0.192‡ 62 (14) 207 (12) 0.565‡
Kidney disease 8 (2) 31 (2) 0.515‡ 13 (3) 37 (2) 0.455‡
Liver disease 8 (2) 24 (1) 0.999‡ 8 (2) 20 (1) 0.374‡
Median number of medical  
comorbidities (IQR)
0 (0 to 1) 0 (0 to 2) < 0.001†§ 2 (1 to 3) 0 (0 to 1) < 0.001†§
Musculoskeletal comorbidity, n (%)
Back pain 274 (53) 725 (47) < 0.013†‡ 214 (47) 653 (38) 0.006†‡
Pain in other joints 358 (69) 1020 (66) < 0.015†‡ 341 (75) 1179 (69) 0.202
Preoperative PROM
Median EQ-5D index (IQR) 0.16 (-0.02 to 0.62) 0.516 (0.09 to 0.69) < 0.001†§ 0.20 (0.06 to 0.69) 0.59 (0.16 to 0.69) < 0.001†§
Mean EQ-5D health (sd) 63.4 (23.7) 68.7 (21.5) < 0.001*† 67.0 (21.1) 70.5 (20.4) < 0.001*†
Mean EQ-5D pain (sd) 47.5 (24.5) 52.0 (23.2) < 0.001*† 50.2 (23.4) 52.3 (22.3) 0.076*
Mean preoperative Oxford score 17.5 (8.5) 20.4 (8.5) < 0.001*† 18.0 (7.8) 20.7 (7.8) < 0.001*†
*Unpaired Student’s t-test
†Statistically significant
‡Chi-squared test
§Mann–Whitney U test
CTD, connective tissue disorder; IQR, interquartile range
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Table IV. Improvement in patient-reported outcome measures (PROMs) at one year following total hip arthroplasty 
(THA; n = 1555) or total knee arthroplasty (TKA; n = 1697) in those ‘worse than death’ (WTD) preoperatively compared 
with those not WTD
PROM improvement 
to 1 yr
WTD preoperative 
mean score (sd)
Not WTD preoperative 
mean score (sd)
p-value 95% CI
Hips n = 248 n = 1307
EQ-5D health 13.3 (29.2) 8.7 (22.8) 0.023*† 0.6 to 8.5
EQ-5D pain 24.8 (37.1) 24.1 (33.4) 0.301* -4.3 to 5.9
EQ-5D status 0.67 (0.3) 0.35 (0.3) < 0.001*† 0.28 to 0.36
Oxford Hip Score 21.6 (11.1) 19.0 (9.4) 0.001*† 1.1 to 4.1
Knees n = 168 n = 1529
EQ-5D health 14.4 (27.6) 5.9 (22.5) < 0.001*† 4.1 to 12.9
EQ-5D pain 23.4 (35.0) 21.1 (33.1) 0.407* -3.1 to 7.6
EQ-5D status 0.58 (0.35) 0.29 (0.32) < 0.001*† 0.24 to 0.34
Oxford Knee Score 16.9 (10.8) 15.0 (9.3) 0.031*† 0.17 to 3.6
*Unpaired Student’s t-test
†Statistically significant
CI, confidence interval; OHS, Oxford Hip Score; EQ-5D, EuroQol five-dimension; OKS, Oxford Knee Score
Table V. Multivariate logistic regression analysis of predictors of per-
sistent ‘worse than death’ (WTD) status in patients WTD preoperatively 
(hips, n = 19; knees, n = 24) compared with patients who were no longer 
WTD at one year following joint arthroplasty (total hip arthroplasty 
(THA), n = 248; total knee arthroplasty (TKA), n = 244). Only variables 
significant at < 10% level on univariate analysis were included
Predictors in the model B OR (95% CI) p-value
Hips (R2 = 0.516)
Liver disease 1.43 4.18 (0.37 to 47.4) 0.248
Back pain 0.84 2.30 (0.39 to 13.6) 0.356
Post-operative Oxford Hip Score 0.07 1.07 (0.96 to 1.21) 0.229
Improvement in Oxford Hip Score 0.13 1.14 (1.0 to 1.30) 0.039*
Improvement in EQ-5D health 0.02 1.02 (1.0 to 1.04) 0.111
Knees (R2 = 0.525)
Preoperative Oxford Knee Score -0.05 0.95 (0.84 to 1.08) 0.437
Post-operative Oxford Knee Score 0.22 1.26 (1.14 to 1.38) < 0.001*
Improvement in EQ-5D pain -0.003 1.00 (0.98 to 1.02) 0.798
Improvement in EQ-5D health 0.02 1.02 (0.99 to 1.04) 0.306
*Statistically significant
OR, odds ratio; CI, confidence interval; EQ-5D, EuroQol five-dimension
Fig. 4
Frequency density graph of preoperative EuroQol five-dimension  
(EQ-5D) index in patients awaiting total knee arthroplasty (TKA) and 
at one year following TKA.
While awaiting TKA, the median EQ-5D index was 0.587 
(IQR 0.29 to 0.88), five patients (0.3%) had an EQ-5D status of 
full health (EQ-5D index = 1.0), and 263 (12.1%) had negative 
scores WTD (Fig. 4). Of 263 patients with health states defined 
as WTD, all reported extreme levels of pain and 69 (26%) 
reported extreme levels of anxiety and depression. Univariate 
analysis confirmed a number of variables to be significantly 
(p < 0.05) associated with WTD status (Table I). Multivari-
ate analysis identified the preoperative OKS and the presence 
of PAD or connective tissue disease (including inflammatory 
arthropathy) to be independently associated with WTD status 
prior to TKA (Table I).
The preoperative EQ-5D status correlated with the preopera-
tive OKS (R = 0.484; p < 0.01, Pearson’s correlation coefficient), 
the EQ-5D health score (R = 0.253; p < 0.01), and the EQ-5D 
pain score (R = 0.182; p < 0.01). Preoperative OKSs were signif-
icantly worse in those with WTD status (Table I, Fig. 5).
ROC analysis using the OKS to predict WTD status gave an 
area under the curve of 0.75 (0.72 to 0.78; p < 0.001; Fig. 6). 
A threshold OKS of 16.5 gave a sensitivity of 71% and a 
specificity of 64% for predicting those WTD. Significant differ-
ences were found in the responses to every individual question 
of the OKS preoperatively between those WTD and those not 
(p < 0.001, chi-squared test).
One year following TKA, 19 patients had died and 1697/2149 
surviving patients (79%) completed follow-up PROMs. Surviv-
ing responders and nonresponders are compared in Table III. In 
responders, the median EQ-5D index improved significantly to 
0.760 (p < 0.001, Wilcoxon’s signed rank test): 493/1697 patients 
(29%) reported an EQ-5D status of 1.0 (i.e. full health) and 53 
patients (3%) had negative scores and were WTD. Those WTD 
preoperatively achieved greater improvements in OKS following 
TKA (Table IV), although their OKS remained significantly worse 
than those not WTD preoperatively at one year (28.5 (sd 11.5) vs 
36.7 (sd 9.1); p < 0.001, Mann–Whitney U test; Fig. 5), a dif-
ference that exceeds the minimal clinically important difference 
for this score of 5.10 Preoperative WTD status was significantly 
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Fig. 5
Oxford Knee Scores (OKSs) prior to and one year following total knee 
arthroplasty (TKA) in patients with preoperative ‘worse than death’ 
(WTD) status (EuroQol five-dimension (EQ-5D) < 0) and in those not 
WTD (EQ-5D > 0). Error bars represent 95% confidence intervals.
Fig. 6
Receiver operating characteristic (ROC) curve for ‘worse than death’ 
(WTD) status and Oxford Knee Score prior to total knee arthroplasty 
(TKA; area under curve = 0.75). Diagonal segments are produced by ties.
associated with satisfaction at one year: 125/164 WTD (73%) vs 
1264/1506 not WTD (84%; p = 0.012, chi-squared test).
A total of 24 patients were persistently WTD at one year. Uni-
variate analysis of those persistently WTD following TKA com-
pared with those no longer WTD demonstrated no differences in 
demographics or comorbidities. Multivariate analysis of associa-
tions significant at the < 10% level (Table V) identified postoper-
ative OKS to be the only independent association with persistent 
WTD status (p < 0.001). WTD rate at one year following TKA 
was significantly higher in those WTD preoperatively: 24/168 
(14%) versus 32/1523 (2%; p < 0.001, chi-squared).
Waiting list data were available for 969 patients (79 WTD). 
Over the study period, the mean waiting time for both OP clinic 
review (p < 0.001, ANOVA) and surgery (p < 0.001, ANOVA) 
increased significantly: mean OP waiting time increased from 
11.1 weeks (sd 2.9) to 23.1 weeks (sd 9.8; p < 0.001, Student’s 
t-test); mean surgery waiting time increased from 13.0 weeks 
(sd 6.2) to 17.1 weeks (sd 6.5; p < 0.001, Student’s t-test). The 
year of surgery affected the rate of WTD status (p = 0.013, chi-
squared test) and was worst in 2016, when 55/437 patients (13%) 
were WTD (Fig. 7). There was no significant difference in wait-
ing times between those reporting a health state WTD and those 
who did not: mean waiting time for new OP review (15.1 weeks 
(sd 7.4) vs 15.6 weeks (sd 5.4); p = 0.577); mean waiting time for 
surgery (14.2 weeks (sd 6.8) vs 14.1 weeks (sd 6.0); p = 0.797).
Discussion
While awaiting lower limb arthroplasty, 19% of patients with 
DJD of the hip and 12% with DJD of the knee reported a health 
state ‘worse than death’, as expressed by the EQ-5D score. This 
was independently associated with joint specific function on 
multivariate analysis. Other associations with WTD status on 
multivariate analysis included COPD and deprivation in hip 
patients, and PAD and connective tissue disorder/inflammatory 
arthropathy in knee patients. Of the variables examined, restric-
tions resulting from joint disease and certain comorbidities 
leave a number of patients in a health state ‘worse than death’ 
as defined by the baseline dataset sampled from the general 
public of the United Kingdom. Patients who were WTD pre-
operatively achieved significantly worse joint-specific Oxford 
scores and satisfaction rates one year following joint arthro-
plasty, compared with those not WTD preoperatively. A trend of 
increasing waiting times over the study period was matched by 
a trend of an increasing proportion of patients WTD, although 
this was only statistically significant for knees.
These results must be interpreted in the context of how the 
EQ-5D score is calculated. The EQ-5D determines 243 health 
states using five domains. The specific score assigned to each 
of the 243 different health states differs by country reflecting 
different population preference weighting. This study of United 
Kingdom patients uses the United Kingdom value set. Results 
may differ with a different country’s preferences.4 The defini-
tion of WTD is researcher-generated and reflects the construc-
tion of the EQ-5D score.4 In the United Kingdom value set, 
one-third of the 243 health states are negative or WTD. These 
were defined by 3395 United Kingdom individuals valuing 
45/243 states using the time trade-off method. Each individual 
scored 13 hypothetical heath states: the less time in the health 
state that could be endured, the lower the score.11 As such, these 
negative WTD scores are a hypothetical value statement made 
by the general public based on their beliefs of health-related 
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quality of life. They do not mean that patients with negative 
scores would rather be dead (i.e. they are not experience-based 
valuations). A recent study of the general Swedish population 
aged more than 65 years found that 1.8% of the 6611 respond-
ents defined a health state WTD using a hypothetical value 
set.11 WTD status was associated with female sex and older age 
reaching 5% in females more than 85 years of age,11 consid-
erably lower than those of patients awaiting joint arthroplasty 
reported here. They also demonstrated that of patients classed 
as WTD, 15% were still satisfied with their life. This implies 
that using a hypothetical value set may underestimate actual 
quality of life and that experiential value sets may be more 
appropriate and accurate at this end of the spectrum. However, 
it is the general public in the United Kingdom who vote for the 
government, often with consideration of how they will fund the 
health service using their taxes, so their opinion of how severe 
illnesses and disabilities may be cared for in a societal context 
is highly relevant, especially when considering rationing and 
prioritization.
Health-related quality of life for a number of medical con-
ditions has been studied using the EQ-5D health index (Table 
VI).3,12-14 It is notable how patients awaiting joint arthroplasty 
surgery score worse on the EQ-5D than patients with other 
chronic medical conditions such as heart failure, diabetes, and 
COPD (Table VI). This may reflect the influence of pain on 
this scoring system: 414/416 patients defined as WTD reported 
extreme pain in this domain of the EQ-5D. Few studies spe-
cifically examine patients with EQ-5D health indices < 0. 
Harrison et al3 investigated predictors of EQ-5D WTD sta-
tus in 700 UK patients with inflammatory arthropathy, find-
ing 9% to be in a health state WTD, associated mainly with 
pain. Similarly, Gaujoux-Viala et al4 reported EQ-5D scores 
in 813 patients with early inflammatory arthropathy, finding 
11% were WTD, the key determinant of which was pain on 
multivariate regression analysis, although poor mental health 
scores (SF-12 MCS) and lower levels of education were also 
associated with a state WTD. Although our results support the 
influence of pain on EQ-5D heath status, social deprivation (as 
a proxy for educational level) was only associated with WTD 
status in hips.
COPD was independently associated with WTD status in 
patients prior to THA. Previous studies have shown signifi-
cant lower limb arthritis to adversely affect cardiopulmonary 
function, and thus end-stage DJD may exacerbate COPD.15,16 
This phenomenon has also been shown to be reversed follow-
ing joint arthroplasty.16,17 Similarly, PAD was identified as an 
The percentage of patients awaiting a) total hip arthroplasty (THA) and b) total knee 
arthroplasty (TKA) defined as ‘worse than death’ (WTD) by year and the total annual 
wait for surgery (from referral to surgery in weeks).
Fig. 7a
Fig. 7b
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independent predictor of WTD status prior to TKA. Again, this 
is not surprising; arthritis increases the cardiovascular effort of 
walking and PAD reduces muscle strength in the limb, prevent-
ing maximum cardiovascular effort.18,19
Although individual waiting times did not predict WTD sta-
tus, the increase in waiting times over the study period was mir-
rored by a rise in the proportion of patients defined as WTD, 
although this was only statistically significant for knee patients. 
Shorter overall waiting times in patients WTD is likely due to 
expedited review and urgent theatre scheduling for patients 
with the most severe disability.
Our study has quantified the extent to which quality of life is 
affected by end-stage DJD. Increasingly, referrals to secondary 
care for joint arthroplasty surgery are being limited by criteria 
such as BMI or Oxford score. Leaving patients to deteriorate 
to negative EQ-5D scores limits the outcome they can achieve 
following joint arthroplasty: patients WTD preoperatively had 
significantly worse Oxford scores one year following THA 
and TKA. Both multivariate and ROC analysis confirmed the 
importance of joint-specific function in determining this poor 
health state, with an OHS of ≤ 14.5 or an OKS of ≤ 16.5 associ-
ated with WTD status. If access to joint arthroplasty is restricted 
by Oxford score, this gives very narrow windows of opportu-
nity in which to operate: OHS 14 to 24; and OKS 16 to 23. 
The low specificity of the ROC analysis, however, calls into 
question using the Oxford scores for this purpose. Discouraging 
referrals for joint arthroplasty by overzealous gatekeeping in 
primary care not only has a potentially negative effect on out-
come, but may also contribute to the growing opiate epidemic, 
as patients with increasingly severe disease are managed non-
operatively in the community.
Limitations of this study include the loss to follow-up of 
nonresponders at one year. Nonresponders had significantly 
worse median EQ-5D indices prior to both THA and TKA than 
responders, and were younger and generally more comorbid. 
Although one-year outcomes were not our primary outcome, 
this may have affected our conclusions regarding improvement 
at one year. Although Oxford scores were significantly differ-
ent statistically between responders and nonresponders, this 
difference did not reach the minimal clinically important differ-
ence. There may be other important covariates that we have not 
included in our analysis. To fully understand the deterioration 
in patient populations that leads to a WTD status, a controlled 
study design would be required. Robust waiting list data were 
not available for all patients. Despite multiple comorbidities 
being investigated specifically, depression and anxiety were 
not. These conditions are known to affect patient satisfaction 
following joint arthroplasty,20 and may affect symptom per-
ception and thus EQ-5D index. Severe levels of self-reported 
anxiety and depression were present, however, in only 76/391 
of WTD hip patients (20%) and 69/263 of WTD knee patients 
(26%). Using the anxiety and depression domain of the EQ-5D 
to predict WTD status is confounded by it being part of the score 
upon which WTD status is based and so was not reported. These 
data are from a United Kingdom population and  analysis was 
performed using United Kingdom EQ-5D weighting. While our 
findings are generalizable to this population, they may not be 
translatable to other countries with different weightings and 
healthcare systems.
A total of 19% of patients with end-stage DJD of the hip 
reported a health state defined as WTD by the EQ-5D score. For 
the knee, this figure was 12%. This end-stage disease was effec-
tively treated with joint arthroplasty surgery with significant 
benefits in both health-related quality of life and joint-specific 
function. WTD status was independently associated with poor 
joint function and specific comorbidities (COPD and PAD) 
rather than the demographic variables examined. Other uniden-
tified confounders may contribute, with the regression models 
here explaining approximately 40% of the variance found. 
From the results presented here, when patients do deteriorate to 
WTD levels, the function they achieve following joint arthro-
plasty, although significantly better than preoperatively, is 
worse than that obtained in patients not WTD prior to surgery. 
Leaving patients in pain with end-stage hip or knee DJD has 
significant consequences on their health-related quality of life 
and ultimately on the outcome of their joint arthroplasty. 
Patients with negative EQ-5D scores should be a priority for 
healthcare delivery.
Take home message
- One-fifth of patients awaiting total hip arthroplasty and 12% 
of patients awaiting total knee arthroplasty are defined as 
in a health state ‘worse than death’ (WTD) by the EuroQol 
five-dimension (EQ-5D) score, a state independently associ-
ated with poor joint function measured using Oxford Hip and 
Knee Scores.
- When patients are in a health state WTD, outcomes are worse following 
arthroplasty.
- It is not benign to delay or deny patients arthroplasty surgery; patients 
with end-stage degenerative joint disease live with pain and disability 
that is more severe than many other chronic health conditions when 
measured using the EQ-5D.
Table VI. EuroQol five-dimension (EQ-5D) index (United Kingdom value sets) for different medical 
conditions
Condition Reference Mean (sd) Median (IQR)
Awaiting THA This study 0.385 (0.32) 0.516 (0.21 to 0.82)
Awaiting TKA This study 0.426 (0.30) 0.587 (0.32 to 0.85)
Asthma Pickard et al12 0.42 (0.3)* N/A
COPD Pickard et al12 0.52 (0.16)* N/A
Inflammatory arthropathy Harrison et al3 N/A 0.590 (0.52 to 0.69)
Heart failure Gallagher et al13 0.64 (0.27) N/A
Diabetes (type II) Nauck et al14 0.78 (0.24) N/A
IQR, interquartile range; THA, total hip arthroplasty; TKA, total knee arthroplasty; COPD, chronic 
obstructive pulmonary disease; N/A, not applicable
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